可靠性强化试验技术在某型伺服作动器研制中的适用性探索

目的探索可靠性强化试验技术在典型机电液一体化产品伺服作动器研制过程中的适用性。方法以某型伺服作动器为研究对象,从故障激发的角度对可靠性强化试验技术的应用进行可行性分析,在响应调查和应力分析的基础上,结合产品的工作特点设计适用于该类伺服作动器的可靠性强化试验方案,包含低温步进应力试验、高温步进应力试验、快速温度循环试验10个循环、振动步进应力试验(包含气锤式三轴向六自由度超高斯随机振动方式及电磁振动台随机振动方式)及综合环境应力试验5个循环,并依此进行试验。结果在快速温度循环试验及综合环境应力试验过程中,均有效地激发出了产品的漏油故障,与相似产品外场暴露的漏油故障模式相吻合。结论可靠性强化试验技术可有效地应用于典型机电液一体化产品伺服作动器的研制过程,设计的可靠性强化试验方案可有效地激发外场出现频率较高的故障,可作为该类产品研制的试验手段之一。     

空间站控制力矩陀螺微振动测试技术

目的分析控制力矩陀螺的微振动扰动特性。方法通过获取陀螺连接点对结构的扰振力输出、关键部位的微振动响应来获取产品的微振动扰动特性,通过隔振的方式对外部环境的干扰进行隔离,进而降低测试的背景噪声,通过运用高精度测试传感器来实现微小扰动力信号、加速度信号的测量,利用结构有限元法及单点激励多点响应的模态分析方法校核系统刚度,进而确定测试频率范围是否满足需求。结果可同时获得空间站控制力矩陀螺连接点处的输出扰振力、质心处的输出扰振力合力、合力矩以及关键部位的微振动响应,可有效隔离外部干扰,扰振力背景噪声的时域信号最大值可控制在0.07 N以内,RMS值在0.02 N以内,加速度信号的时域背景噪声最大值可控制在1.5 mg以内,RMS值在0.1 mg以内。可识别微小扰振信号,加速度传感器分辨率为5×10-5 grms,力传感器的测量分辨率为1×10-2 N,力矩测量分辨率小于1×10-2 N·m。测试频带在320 Hz以内。结论满足型号需求,并投入型号使用。     

海河下游水体中DO与NH_3-N、COD_(Mn)相关关系探讨

本文应用近年来海河下游监测数据对ＤＯ与ＮＨ３Ｎ和ＣＯＤＭｎ进行一元线性回归，得到两回归方程：ＮＨ３Ｎ＝－１２８ＤＯ＋１０５４；ＣＯＤＭｎ＝－１１３ＤＯ＋１６９２。并经相关系数和回归系数显著性检验，表明在９９９％的置信水平下ＤＯ与ＮＨ３Ｎ和ＣＯＤＭｎ线性相关均极其显著     

甘肃寒山金矿区黄钾铁矾的形成机制及其地质意义

在分析寒山金矿区原生矿物和氧化矿物组合的基础上，通过对黄钾铁钒的热力学计算分析得出：在常温条件下，黄铁矿要形成黄钾铁钒，所需的氧逸度较低，但需要有一个较高的碱性、富钾、富Fe2＋以及富水的环境，这一条件暗示了围岩为富铁的基性火山岩在湿润的气候条件下有利于形成黄钾铁钒，同时也表明寒山金矿区氧化带的形成过程中，其气侯环境不是现在的沙漠干旱气候，而是湿润动植物繁盛的大陆性气候。结合区域地质特征，可以得出寒山金矿的氧化带可能形成于早侏罗世-中侏罗世。     

论环境参与权

环境参与权是公民享有的一项重要环境权利。它包括参与环境立法权、环境行政听证权、参与环境决策权和环境监督权，确立环境参与权具有重要意义，但我国现行立法很不完备，需要进一步完善。     

Prenatal diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency by steroid analysis in the amniotic fluid of mid-pregnancy: Comparison with HLA typing in 17 pregnancies at risk for CAH

Amniotic fluid (AF) levels of 17-hydroxyprogesterone (17OHP) and testosterone (T) were determined at 16–17 weeks in 17 pregnancies at risk for CAH and results compared to 75 normal controls. The fetus was predicted to be unaffected in 12 cases on the findings of normal AF levels of both 17OHP and T and the latter allowed a correct prediction of fetal sex in all instances. HLA typing confirmed normality in 12 cases revealing 5 carriers, 5 homozygous normal and 2 indeterminate. Steroid levels of the 2 groups were similar. Three fetuses were predicted to be CAH affected on unambiguously high levels of 17OHP and T (in female only). HLA typing was in agreement, and the diagnosis was confirmed in 2 abortuses and a female newborn by physical and hormonal studies. In the last 2 cases AF levels of OHP and T were normal but HLA (A/B/C) genotypes were identical to the CAH affected siblings. Normal physical and hormonal findings in the 2 aborted fetuses would exclude the possibility of an in utero virilizing form of CAH. The discrepancy could be explained on the basis that the fetuses had an allelic form of 21-hydroxylase deficiency or on the basis of recombination (not fully tested). It is concluded that a fully informative prenatal diagnosis of CAH should not rely entirely on HLA typing but on hormonal studies.     

Prenatal diagnosis of spinal muscular atrophy in Russia

Ninety-two families with spinal muscular atrophy (SMA) applied for genetic counselling and further prenatal diagnosis. To minimize expenses, only one tightly linked informative marker was determined in the course of preliminary examination, and non-radioactive allele detection was preferably used. Four prenatal diagnoses of SMA type I, four of SMA type II, and one of SMA type III were made. This trial programme shows the considerable requirements, importance, and potential effectiveness of prenatal prediction of SMA in Russia.     

Neural tube defects in trisomy 18

In a retrospective survey, the incidence of neural tube defects in liveborn trimsomy 18 was found to be 6·2 per cent. Based on these data one would expect to find trisomy 18 in 1 of the 117 patients with myeloidysplasia; the incidence of trisomy 18 in dysraphic fetuses would be anticipated to be higher. These observations underscore the need for amniocentesis karyotyping of fetuses with neural tube defects, and the importance of careful examination of infants born with neural tube defects.     

Technical and theoretical considerations in the HLA typing of amniotic fluid cells for prenatal diagnosis and paternity testing

HLA typing of amniotic fluid cells has been used for the prenatal diagnosis of the HLA linked diseases congenital adrenal hyperplasia (21-OH-deficiency (21-OH-def) type) and complement C4 deficiency and it has also been used for the prenatal de termination of paternity. There are, however, technical difficulties in this test associated with the weak expression of some B locus antigens on amniotic fluid cells, and theoretical difficulties related to associations between particular HLA antigens and the 21-OH-def allele. Since certain HLA-B locus antigens are found in significantly increased frequencies among patients with 21-OH-def, there is a relatively high incidence of HLA-B homozygosity among the patients and over 40 percent of the parents of these patients share one or more HLA-B locus antigens. Results of some prenatal HLA typing tests may thus be difficult to interpret, and supplementary tests should be used whenever possible. HLA typing of amniotic cells is, however, the only available procedure for prenatal diagnosis of C4 deficiency and it is the best available procedure for prenatal determination of paternity. A modification of our original procedure allows HLA typing to be performed with increased numbers of HLA typing sera, and sera with optimum reactivity for amniotic fluid cells have now been selected for the definition of most of the more commonly expressed HLA antigens. Although amniotic fluid cells do not express DR antigens, amniotic fluid cells can be typed for the HLA-linked marker glyoxalase I (GLO) and this may be the informative for prenatal diagnosis in some cases.